Value20202021202220232024TTMSelling/general/admin expenses62.76 M24.11 M24.98 M30.73 M43.62 M67.48 MResearch & development41.38 M39.35 M50.56 M61.36 M81.33 M103.74 MOperating income49.36 M61.41 M72.94 M92.08 M114.96 M160.24 MNon-Operating Income, Total1.83 M181 K1.26 M6.32 M4.27 M4.11 MInterest expense, net of interest capitalized15.79 M9.97 M2.14 M4.14 M4.56 M1.87 MNon-Operating Income, excl. Interest Expenses-15.28 M-11.1 M-922 K2.08 M-413 K2.06 MUnusual income/expense1.31 M1.31 M47 K109 K123 K179 KPretax income67.53 M71.2 M73.81 M98.18 M130.45 M50.62 MEquity in earnings——————Taxes194 K00-18.5 M185 K185 KNon-controlling/minority interest——————After tax other income/expense——————Net income before discontinued operations67.73 M71.2 M73.81 M87.37 M130.64 M241.11 MDiscontinued operations——————Net income67.73 M71.2 M73.81 M87.37 M130.64 M241.11 MDilution adjustment——————Preferred dividends——————Diluted net income available to common stockholders67.73 M71.2 M73.81 M87.37 M130.64 M261.43 MBasic earnings per share (Basic EPS)-5.28-4.92-4.56-3.96-3.66-4.19Diluted earnings per share (Diluted EPS)-5.28-4.92-4.56-3.93-3.66-4.42Average basic shares outstanding12.78 M14.53 M16.14 M22.05 M35.71 M229.19 MDiluted shares outstanding12.78 M14.53 M16.14 K22.05 M35.71 M237.08 MEBITDA-9.58 M—————EBIT-21.99 M—————Cost of revenue793 K—————Other cost of goods sold——————Depreciation & amortization (cash flow)12.41 M9.53 M328 K1.23 M31 K815 K
Verastem Inc
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.